BCI
ICPT

Brinker Capital Investments’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Brinker Capital Investments’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1
Closed – – 671
2016
Q3 		$0 Buy
+1
New +$158 ﹤0.01% 642
2016
Q1 		– Sell
-4
Closed -$1K – 717
2015
Q4 		$1K Buy
4
+1
+33% +$169 ﹤0.01% 552
2015
Q3 		$0 Buy
+3
New +$660 ﹤0.01% 524

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Brinker Capital Investments's ICPT Position: Q4 2016 in Review

Brinker Capital Investments sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 1 share.

Brinker Capital Investments first reported a position in ICPT in Q3 2015 and held it in 3 quarters. The position peaked at $1K in Q4 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Brinker Capital Investments reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Brinker Capital Investments sold 1 Intercept Pharmaceuticals, Inc. share in Q4 2016.
  • Brinker Capital Investments first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 3 quarters.
  • Brinker Capital Investments's Intercept Pharmaceuticals, Inc. position peaked at $1K in Q4 2015.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Brinker Capital Investments's 13F filing for Q4 2016, filed 8 Feb 2017.